Glycerophosphate is interchangeable with inorganic phosphate in terms of safety and serum pharmacokinetics

Pharmacology

Volumn 88, Issue 3-4, 2011, Pages 193-200

  Topp, Heinrich ^a   Hochfeld, Olena ^a   Bark, Staffan ^c   Grossmann, Matthias ^b   Joukhadar, Christian ^d,e,f   Westphal, Martin ^a   Straatsma, Harald ^a   Rothenburger, Markus ^a  

^a Fresenius Kabi Deutschland GmbH   (Germany)

^b PAREXEL INTERNATIONAL   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d J & P Medical Research Ltd   (Austria)

^e Beth Israel Deaconess Medical Center   (Israel)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Interaction; Parenteral nutrition; Phosphorus

Indexed keywords

CALCITONIN; CALCIUM; GLYCEROPHOSPHATE; GLYCOPHOS; INORGANIC SODIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; SODIUM; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACKACHE; BIOEQUIVALENCE; CALCIUM BLOOD LEVEL; COMMON COLD; CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; FEMALE; HEADACHE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; HYPOCALCEMIA; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; SUPRAVENTRICULAR PREMATURE BEAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; AREA UNDER CURVE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GLYCEROPHOSPHATES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PHOSPHATES; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 80052756460     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000331341     Document Type: Article

References (16)

1. Taylor DJ, Coppack SW, Cadoux-Hudson TA, Kemp GJ, Radda GK, Frayn KN, Ng LL: Effect of insulin on intracellular pH and phosphate metabolism in human skeletal muscle in vivo. Clin Sci (Lond) 1991; 81: 123-128.
2. Reilly RF: Disorders of serum phosphorus; in Reilly RF, Perazella MA (eds): Nephrology in 30 Days. New York, McGraw Hill, 2005, pp 161-176.
3. Amanzadeh J, Reilly RF Jr: Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2006; 2: 136-148. (Pubitemid 43355193)
4. Martínez MJ, Martínez MA, Montero M, Campelo E, Castro I, Inaraja MT: Hypophosphatemia in postoperative patients with total parenteral nutrition: influence of nutritional support teams. Nutr Hosp 2006; 21: 657-660. (Pubitemid 46089923)
5. Croner S, Larsson J, Schildt B, Symreng T: Severe anorexia nervosa treated with total parenteral nutrition: clinical course and influence on clinical chemical analyses. Acta Paediatr Scand 1985; 74: 230-236. (Pubitemid 15137078)
6. Costello I, Powell C, Williams AF: Sodium glycerophosphate in the treatment of neonatal hypophosphataemia. Arch Dis Child Fetal Neonatal Ed 1995; 73:F44-F45.
7. Nilsson E: An open study with sodium glycerophosphate-to document safety and metabolism of sodium glycerophosphate in post-operative patients requiring TPN. Kabi Pharmacia Scientific Report 9196531. 1991.
8. Topp H, Hochfeld O, Bark S, Grossmann M, Joukhadar C, Westphal M, Straatsma H, Rothenburger M: Glycerophosphate does not interact with components of parenteral nutrition. Pharmacology 2011;88:114-120.
9. CPMP/EWP/QWP/1401/98: the European Agency for the Evaluation of Medicines for human use. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific- guideline/2009/09/WC500003519.pdf (accessed May 14, 2011).
10. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products-general considerations. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf (accessed May 14, 2011).
11. Friede T, Kieser M: Blinded sample size reassessment in non-inferiority and equivalence trials. Stat Med 2003; 22: 995-1007. (Pubitemid 36322099)
12. Wilimzig C, Latz R, Vierling W, Mutschler E, Trnovec T, Nyulassy S: Increase in magnesium plasma level after orally administered trimagnesium dicitrate. Eur J Clin Pharmacol 1996; 49: 317-323. (Pubitemid 26035852)
13. Portale AA, Halloran BP, Morris RC Jr: Dietary intake of phosphoros modulates the circadian rhythm in serum concentration of phosphorus: implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987; 80: 1147-1154. (Pubitemid 18075654)
14. Jubiz W, Canterbury JM, Reiss E, Tyler FH: Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. Clin Invest 1972; 51: 2040-2046.
15. Zander-Burman M, Björkner E, Carneheim C: The in vitro hydrolysis of glycerophosphate in human plasma. Kabi Pharmacia Scientific Report 9196525. 1992.
16. Institute of Medicine, Food and Nutrition Board: Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, National Academy Press, 1997, pp 146-189.